• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 19, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Researchers uncover previously unstudied cancer enzyme

Bioengineer by Bioengineer
September 12, 2018
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers do not know how all the proteins and enzymes in the human body function, far from it. Now researchers at the University of Copenhagen have come a bit closer to understanding how an enzyme that appears to be important to cancer development behaves inside the cells.

The new study that has just been published in the scientific journal Nature Communications shows first of all that the enzyme METTL13 helps control the formation of new proteins in the cells.

'Mistakes in the production of proteins are undesirable, as we know from other studies that it can result in the development of cancer tumours and degenerative brain disorders like Alzheimer's and Parkinson's. Therefore, the new knowledge of how this enzyme functions is significant', says Professor Jesper Velgaard Olsen from the Novo Nordisk Foundation Center for Protein Research.

The enzyme helps control protein synthesis by placing so-called methyl marks on a particular protein called eEF1A.

'If methyl is not attached correctly to the protein it will not be able to do its job properly. And that again affects the formation of proteins in the cell, which will take place at a suboptimal pace, and even though that may not sound so bad, it appears to be connected with very serious disorders', says Postdoc Magnus Jakobsson from the Novo Nordisk Foundation Center for Protein Research.

The researchers have shown how the enzyme functions by studying isolated human cancer cells using advanced mass spectrometers which, in short, are able to identify and quantify proteins and their methyl-modifications in a cell.

Now the researchers hope the study will lead to the development of methods and drugs able to target and assure the enzyme to function as intended in our cells.

###

The study is funded by the Lundbeck Foundation and the Novo Nordisk Foundation, among others.

Media Contact

Jesper Velgaard Olsen
[email protected]
45-35-32-50-22

http://healthsciences.ku.dk/

https://healthsciences.ku.dk/news/2018/09/researchers-uncover-previously-unstudied-cancer-enzyme/

Related Journal Article

http://dx.doi.org/10.1038/s41467-018-05646-y

Share12Tweet7Share2ShareShareShare1

Related Posts

AI Model Delivers Precise and Transparent Insights to Enhance Autism Assessments

AI Model Delivers Precise and Transparent Insights to Enhance Autism Assessments

September 19, 2025
blank

Collaboration with Kenya’s Turkana Community Uncovers Genes Behind Desert Adaptation

September 18, 2025

Cracking the Code of the Selfish Gene: From Evolutionary Cheaters to Breakthroughs in Disease Control

September 18, 2025

New Model Enables Precise Predictions of Forest Futures

September 18, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    155 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Targeting Lipid Metabolism to Enhance Antitumor Immunity

Triple Wavefront Modulation Enables Advanced Multi-Depth XR Vision

Uncovering Gaps in Rehab for Hospitalized Patients

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.